Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2412272589;72590;72591 chr2:178573768;178573767;178573766chr2:179438495;179438494;179438493
N2AB2248167666;67667;67668 chr2:178573768;178573767;178573766chr2:179438495;179438494;179438493
N2A2155464885;64886;64887 chr2:178573768;178573767;178573766chr2:179438495;179438494;179438493
N2B1505745394;45395;45396 chr2:178573768;178573767;178573766chr2:179438495;179438494;179438493
Novex-11518245769;45770;45771 chr2:178573768;178573767;178573766chr2:179438495;179438494;179438493
Novex-21524945970;45971;45972 chr2:178573768;178573767;178573766chr2:179438495;179438494;179438493
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Fn3-63
  • Domain position: 1
  • Structural Position: 1
  • Q(SASA): 0.629
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/K None None 0.214 N 0.238 0.116 0.156986980423 gnomAD-4.0.0 1.38048E-06 None None None None I None 0 0 None 0 0 None 0 0 1.80959E-06 0 0
R/S None None 0.953 N 0.657 0.253 0.218112801441 gnomAD-4.0.0 6.90221E-07 None None None None I None 0 0 None 0 0 None 0 0 9.04743E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.6946 likely_pathogenic 0.7003 pathogenic -0.06 Destabilizing 0.964 D 0.559 neutral None None None None I
R/C 0.2215 likely_benign 0.244 benign -0.156 Destabilizing 1.0 D 0.858 deleterious None None None None I
R/D 0.9556 likely_pathogenic 0.9603 pathogenic -0.081 Destabilizing 0.99 D 0.765 deleterious None None None None I
R/E 0.7368 likely_pathogenic 0.7461 pathogenic -0.023 Destabilizing 0.931 D 0.51 neutral None None None None I
R/F 0.8112 likely_pathogenic 0.8034 pathogenic -0.277 Destabilizing 0.998 D 0.815 deleterious None None None None I
R/G 0.6594 likely_pathogenic 0.6928 pathogenic -0.251 Destabilizing 0.953 D 0.501 neutral N 0.491913851 None None I
R/H 0.2045 likely_benign 0.2283 benign -0.699 Destabilizing 0.998 D 0.598 neutral None None None None I
R/I 0.3562 ambiguous 0.3373 benign 0.406 Stabilizing 0.993 D 0.842 deleterious N 0.4513997 None None I
R/K 0.1351 likely_benign 0.1423 benign -0.106 Destabilizing 0.214 N 0.238 neutral N 0.440545588 None None I
R/L 0.4747 ambiguous 0.4649 ambiguous 0.406 Stabilizing 0.964 D 0.501 neutral None None None None I
R/M 0.487 ambiguous 0.4851 ambiguous 0.034 Stabilizing 1.0 D 0.57 neutral None None None None I
R/N 0.8636 likely_pathogenic 0.8749 pathogenic 0.184 Stabilizing 0.99 D 0.599 neutral None None None None I
R/P 0.8912 likely_pathogenic 0.9048 pathogenic 0.271 Stabilizing 0.995 D 0.849 deleterious None None None None I
R/Q 0.1759 likely_benign 0.1834 benign 0.048 Stabilizing 0.99 D 0.642 neutral None None None None I
R/S 0.7642 likely_pathogenic 0.7839 pathogenic -0.198 Destabilizing 0.953 D 0.657 prob.neutral N 0.464908826 None None I
R/T 0.4309 ambiguous 0.4446 ambiguous -0.01 Destabilizing 0.993 D 0.546 neutral N 0.50378899 None None I
R/V 0.4644 ambiguous 0.4474 ambiguous 0.271 Stabilizing 0.995 D 0.831 deleterious None None None None I
R/W 0.4691 ambiguous 0.5022 ambiguous -0.305 Destabilizing 1.0 D 0.877 deleterious None None None None I
R/Y 0.6758 likely_pathogenic 0.6976 pathogenic 0.093 Stabilizing 0.998 D 0.829 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.